| Literature DB >> 31383669 |
Yumi Park1, Yong-Mo Ahn1, Surendranadha Jonnala1, Sangmi Oh1, Julia M Fisher1, Michael B Goodwin1, Thomas R Ioerger2, Laura E Via1, Tracy Bayliss3, Simon R Green3, Peter C Ray3, Paul G Wyatt3, Clifton E Barry1, Helena I Boshoff4.
Abstract
Mechanisms of magnesium homeostasis in Mycobacterium tuberculosis are poorly understood. Here, we describe the characterization of a pyrimidinetrione amide scaffold that disrupts magnesium homeostasis in the pathogen by direct binding to the CorA Mg2+/Co2+ transporter. Mutations in domains of CorA that are predicted to regulate the pore opening in response to Mg2+ ions conferred resistance to this scaffold. The pyrimidinetrione amides were cidal against the pathogen under both actively replicating and nonreplicating conditions in vitro and were efficacious against the organism during macrophage infection. However, the compound lacked efficacy in infected mice, possibly due to limited exposure. Our results indicate that inhibition of Mg2+ homeostasis by CorA is an attractive target for tuberculosis drug discovery and encourage identification of improved CorA inhibitors.Entities:
Keywords: CorA transporter; Mycobacterium tuberculosiszzm321990; magnesium homeostasis; pyrimidinetrione amide; structure-activity relationship
Mesh:
Substances:
Year: 2019 PMID: 31383669 PMCID: PMC6761525 DOI: 10.1128/AAC.01006-19
Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN: 0066-4804 Impact factor: 5.191